Alteration to hippocampal shape in cannabis users with and without schizophrenia

Schizophrenia Research

Volumn 143, Issue 1, 2013, Pages 179-184

  Solowij, Nadia ^a,b   Walterfang, Mark ^c,d   Lubman, Dan I ^e   Whittle, Sarah ^c   Lorenzetti, Valentina ^c   Styner, Martin ^f,g   Velakoulis, Dennis ^c,d   Pantelis, Christos ^c   Yücel, Murat ^c  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g Brooks Computer Science Building   (United States)

Author keywords

Cannabis; Hippocampus; Neuroimaging; Schizophrenia; Shape analysis

Indexed keywords

CANNABIS;

ADULT; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BRAIN SIZE; CANNABIS ADDICTION; CLINICAL ARTICLE; CONTROLLED STUDY; HIPPOCAMPAL SHAPE; HIPPOCAMPUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHIZOPHRENIA; SCORING SYSTEM; SMOKING; SYMPTOM;

ADULT; BRAIN MAPPING; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SCHIZOPHRENIA; STATISTICS AS TOPIC;

EID: 84871933160     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.10.040     Document Type: Article

References (24)

1. Andreasen N.C. The Scales for the Assessment of Positive (SAPS) and Negative (SANS) Symptoms 1983, University of Iowa, Iowa City.
2. Ashtari M., Avants B., Cyckowski L., Cervellione K.L., Roofeh D., Cook P., et al. Medial temporal structures and memory functions in adolescents with heavy cannabis use. J. Psychiatr. Res. 2011, 45(8):1055-1066.
3. Brechbuhler C., Gerig G., Kubler O. Parameterization of closed surfaces for 3-D shape description. Comput. Vis. Image Underst. 1995, 61(2):154-170.
4. Csernansky J.G., Wang L., Jones D., Rastogi-Cruz D., Posener J.A., Heydebrand G., et al. Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. Am. J. Psychiat. 2002, 159(12):2000-2006.
5. D'Souza D.C., Sewell R.A., Ranganathan M. Cannabis and psychosis/schizophrenia: human studies. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259(7):413-431.
6. Glass M., Dragunow M., Faull R.L.M. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997, 77(2):299-318.
7. Habets P., Marcelis M., Gronenschild E., Drukker M., van Os J. Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia. Biol. Psychiatry 2011, 69(5):487-494.
8. Koskinen J., Löhönen J., Koponen H., Isohanni M., Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr. Bull. 2010, 36(6):1115-1130.
9. Lorenzetti V., Lubman D.I., Whittle S., Solowij N., Yücel M. Structural MRI findings in long-term cannabis users: what do we know?. Subst. Use Misuse 2010, 45:1787-1808.
10. Murray R.M., Morrison P.D., Henquet C., Di Forti M. Cannabis, the mind and society: the hash realities. Nat. Rev. Neurosci. 2007, 8(11):885-895.
11. Paniagua B., Styner M., Macenko M., Pantazis D., Niethammer M. Local Shape Analysis Using MANCOVA. Insight 2009, 1-21. (http://hdl.handle.net/10380/3124).
12. Pantazis D., Leahy R., Nichols T., Styner M. Statistical surface-based morphometry using a non-parametric approach. 2nd IEEE Int. Symp. Biomed. Imaging: Macro to Nano 2004, vol. 1 & 2:1283-1286.
13. Rais M., Cahn W., Van Haren N., Schnack H., Caspers E., Hulshoff Pol H., et al. Excessive brain volume loss over time in cannabis-using first episode schizophrenia patients. Am. J. Psychiat. 2008, 165(4):490-496.
14. Small S.A., Schobel S.A., Buxton R.B., Witter M.P., Barnes C.A. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat. Rev. Neurosci. 2011, 12(10):585-601.
15. Smith M.J., Wang L., Cronenwett W., Goldman M.B., Mamah D., Barch D., et al. Alcohol use disorders contribute to hippocampal and subcortical shape differences in schizophrenia. Schizophr. Res. 2011, 131(1-3):174-183.
16. Solowij N., Michie P.T. Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?. J. Psychiatr. Neurosci. 2007, 32(1):30-52.
17. Solowij N., Yücel M., Lorenzetti V., Lubman D.I. Does cannabis cause lasting brain damage?. Marijuana and Madness 2012, 103-113. Cambridge University Press, Cambridge. 2nd ed. D. Castle, R. Murray, D.C. D'Souza (Eds.).
18. Solowij N., Yücel M., Respondek C., Whittle S., Lindsay E., Pantelis C., et al. Cerebellar white matter changes in cannabis users with and without schizophrenia. Psychol. Med. 2011, 41(11):2349-2359.
19. Styner M., Lieberman J., Pantazis D., Gerig G. Boundary and medial shape analysis of the hippocampus in schizophrenia. Med. Image Anal. 2004, 8(3):197-203.
20. Styner M., Oguz I., Xu S., Brechbuhler C., Pantazis D., Levitt J., et al. Framework for the Statistical Shape Analysis of Brain Structures Using SPHARM-PDM 2006, (Insight: http://hdl.handle.net/1926/215).
21. Tamminga C.A., Stan A.D., Wagner A.D. The hippocampal formation in schizophrenia. Am. J. Psychiatry 2010, 167(10):1178-1193.
22. Velakoulis D., Pantelis C., McGorry P.D., Dudgeon P., Brewer W., Cook M., et al. Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch. Gen. Psychiatry 1999, 56(2):133-141.
23. Villares J. Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain. Neuroscience 2007, 145:323-334.
24. Yücel M., Solowij N., Respondek C., Whittle S., Fornito A., Pantelis C., et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch. Gen. Psychiatry 2008, 65(6):694-701.